The HPV testing and Pap test industry is growing rapidly and is expected to continue growing in the foreseeable future. According to a recent study, the global HPV testing and Pap test market size is projected to reach USD 9.2 billion by 2027 from USD 4.9 billion in 2022, at a CAGR of 13.2% during the forecast period. Growth in the HPV testing and Pap test market is mainly driven by factors such as the increase in favorable regulations in diagnostic companies and increase in number of cancer cases.
Download PDF Brochure: https://www.marketsandmarkets.com/requestsampleNew.asp?id=214207371
HPV testing and Pap test market Top Segments
- The market is segmented into HPV Testing and Pap Test. The HPV testing segment accounted for the largest share of this market, mainly due to the rising investment for development of new cervical diagnostic products.
- The market is segmented into cervical cancer screening and vaginal cancer screening. The cervical cancer screening segment accounted for the largest share of this market, mainly due to the rising increased initiatives by women for cervical cancer screening.
- The market is segmented into laboratories, hospitals and physician’s offices & clinics based on end user. The hospitals segment accounted for the largest share. Factors such as increased need of cervical cancer screening to market growth.
Innovation in HPV Testing Pap Test Market
- Automated HPV Testing: Automated HPV testing is becoming increasingly popular in the Pap test industry. Automated testing can detect high-risk HPV types and can provide results in a shorter time frame than traditional methods. Additionally, the automation process can reduce the potential for human error.
- Molecular Testing: Molecular testing is becoming increasingly popular in the Pap test industry. This type of testing uses DNA to identify high-risk HPV types and can provide results in a shorter time frame than traditional methods.
- Liquid-Based Cytology: Liquid-based cytology has become increasingly popular in recent years. This method uses a liquid solution to preserve cells and can provide more accurate results than traditional methods.
- Point-of-Care Testing: Point-of-care testing is becoming increasingly popular in the Pap test industry. This type of testing uses a handheld device to detect high-risk HPV types and can provide results in a shorter time frame than traditional methods.
- Self-Sampling: Self-sampling is becoming increasingly popular in the Pap test industry. This type of testing allows patients to collect their own sample and send it to a laboratory for testing. Self-sampling can be a more convenient
Some of the prominent key players are:
- Abbott Laboratories (US),
- Roche Diagnostics (Switzerland),
- Becton, Dickinson and Company (US),
- Hologic, Inc. (US),
- Quest Diagnostics (US),
- Qiagen N.V. (Netherland),
- Seegene, Inc. (US),
- Femasys, Inc. (US),
- Arbor Vita Corporation (US) and many more…….
In 2021, Abbott Laboratories (US) held the leading position in the HPV testing and Pap test market. The company has maintained a leading position in the market through its strong presence across North America.he company also adopts organic growth strategies to increase its dominance in this market by innovating new products to increase the product range. The company has a wide distribution network spread across over 150 countries and 291 subsidaries.
In 2021, Roche Diagnostics (Switzerland) held the second position in the HPV testing and Pap test market. It has a increased presence in North America, Europe and the Asia Pacific with a strong network and growth strategies. Roche focuses on increasing R&D with increased investment for innovation. The company has strong presence in North America and its major share comes from US
Request Sample Pages: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=214207371
The global HPV testing and Pap test market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest regional market for HPV testing and Pap test market. The large share of North America in this market can be attributed to the governments support for cancer research in the region.
